Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 6, 2008, Pages 501-507

  Fischer, Peter ^a,b,e   Zehetmayer, Sonja ^c   Jungwirth, Susanne ^a   Weissgram, Silvia ^a   Krampla, Wolfgang ^a   Hinterberger, Margarete ^a   Torma, Sabine ^a,b   Rainer, Michael ^a,b   Huber, Klaus ^b   Hoenigschnabl, Selma ^b   Gelpi, Ellen ^d   Bauer, Kurt ^b   Leitha, Thomas ^b   Bauer, Peter ^c   Tragl, Karl Heinz ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b DANUBE HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Otto Wagner Spital   (Austria)

Author keywords

Alzheimer, risk factors; Cohort study; Dementia, Alzheimer

Indexed keywords

FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLIC ACID BLOOD LEVEL; GENE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ALZHEIMER DISEASE; AUSTRIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 46849094315     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128577     Document Type: Article

References (33)

1. Ritchie K, Lovestone S: The dementias. Lancet 2002;360:1759-1766.
2. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, the EURODEM Incidence Research Group and Work Groups: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999;52:78-84.
3. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
4. Green RC, Cupples A, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachmann D, Farrer L: Depression as a risk factor for Alzheimer disease: the Mirage study. Arch Neurol 2003;60:753-759.
5. Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S: Diabetes mellitus and risk of developing Alzheimer disease. Arch Neurol 2006;63:1551-1555.
6. Razay G, Vreugdenhil A, Wilcock G: The metabolic syndrome and Alzheimer disease. Arch Neurol 2007;64:93-96.
7. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH: Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-1521.
8. Etminan M, Gill S, Samii A: The role of lipidlowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003;23:726-730.
9. de Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG: Meta-analysis on nonsteroidal anti-inflammatory drug use and risk of dementia. Am J Epidemiol 2005;161:114-120.
10. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I: Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol 2002;156:445-453.
11. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F: Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636-643.
12. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Dalmonte E, Bianchin M, Mariani E: Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005;64:1525-1530.
13. Karp A, Kareholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L: Relation of education and occupation-based socio-economic status to incident Alzheimer's disease. Am J Epidemiol 2004;159:175-183.
14. Fischer P, Jungwirth S, Krampla W, Weissgram S, Kirchmeyr W, Schreiber W, Huber K, Rainer M, Bauer P, Tragl KH: Vienna-Transdanube-Aging 'VITA': study design, recruitment strategies and level of participation. J Neural Transm Suppl 2002;62:103-114.
15. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, CERAD investigators: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
16. Judd LL, Rapaport MH, Paulus MP, Brown JL: Subsyndromal symptomatic depression: a new mood disorder? J Clin Psychiatry 1994;55(suppl):18-28.
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Bäckman L: The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
20. Johnson DK, Wilkins CH, Morris JC: Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 2006;63:1312-1317.
21. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB: Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 2002;59:1737-1746.
22. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL: Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006;63:168-174.
23. Andersen K, Lolk A, Sorensen PK, Petersen NE, Green A: Depression and the risk of Alzheimer disease. Epidemiology 2005;16:233-238.
24. Eaton WW, Neufeld K, Chen LS, Cai G: A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry 2000;57:217-222.
25. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Bäckman L: The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
26. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D, Albarede JL, Vellas B: Weight loss in Alzheimer disease. Am J Clin Nutr 2000;71:637-642.
27. Jorm AF: Is depression a risk factor for dementia or cognitive decline? Gerontology 2000;46:219-227.
28. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RG, de Craen AJ: Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-plus study. Am J Clin Nutr 2005;82:866-871.
29. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R: Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007;64:86-92.
30. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB: The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
31. Katzmann R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
32. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH, et al: Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007;68:288-291.
33. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R: Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-551.